TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31969977

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 International Units once daily for 4 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 40
Study: 30865782

Group type: EXPERIMENTAL
Intervention: Technology-based delivery
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Small group delivery
Number of subjects: 421

Group type: COMPARATOR
Intervention: Literature control
Number of subjects: 421
Study: 29062019

Group type: EXPERIMENTAL
Intervention: Pattern recognition control
Number of subjects: 8

Group type: COMPARATOR
Intervention: Direct control
Number of subjects: 8
Study: 25701159

Group type: EXPERIMENTAL
Intervention: Standard parenteral nutrition with glutamine supplementation (SPN + Gln)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard parenteral nutrition (SPN)
Number of subjects: 98
Study: 24057919

Group type: EXPERIMENTAL
Intervention: Visible light‐cured resin (VLCR) dentures
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional poly(methyl methacrylate) (PMMA) dentures
Number of subjects: 52
Study: 22052028

Group type: EXPERIMENTAL
Intervention: Treadmill exercise at intensities of 10, 12, 14, 15 and 16 km/h (0% gradient)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cycle ergometer exercise at intensities of 80, 120, 160, 180 and 200 W (65‐70 rpm)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Treadmill and cycle ergometer exercise
Number of subjects: 20
Study: 19539361

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (5-20 mg, once daily or twice daily)
Number of subjects: 3491

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 3491

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3491
Study: 17292895

Group type: COMPARATOR
Intervention: 600 IU of recombinant follicle-stimulating hormone (FSH) as the control group (group A)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: 600 IU of recombinant FSH plus daily supplementation with 75 IU of recombinant luteinizing hormone (group B)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: 600 IU of recombinant FSH plus daily supplementation with 75 IU of recombinant hCG (group C)
Number of subjects: 170
Study: 15238155

Group type: EXPERIMENTAL
Intervention: International Postage Vouchers
Number of subjects: 0

Group type: COMPARATOR
Intervention: No return postage
Number of subjects: 0
Study: 11575982

Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg, orally, 4 times daily for 2 days
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo, orally, 4 times daily for 2 days
Number of subjects: 201
Study: 10230643

Group type: EXPERIMENTAL
Intervention: Insulin therapy with metformin
Number of subjects: 26

Group type: COMPARATOR
Intervention: Insulin therapy without metformin
Number of subjects: 26
Study: 8556969

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both Methadone and Clonidine
Number of subjects: 16
Study: 2528477

Group type: EXPERIMENTAL
Intervention: Second-look operative laparoscopy after salpingo‐ovariolysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second-look operative laparoscopy after salpingostomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expectant observation after salpingo‐ovariolysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expectant observation after salpingostomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second-look operative laparoscopy
Number of subjects: 0
Study: 826960

Group type: COMPARATOR
Intervention: Adrenaline injections
Number of subjects: 10
Study: 30572378

Group type: EXPERIMENTAL
Intervention: Peer support education mode
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 26534874

Group type: EXPERIMENTAL
Intervention: 400μg buccal misoprostol
Number of subjects: 120

Group type: COMPARATOR
Intervention: 800μg placebo buccal
Number of subjects: 120
Study: 24585400

Group type: EXPERIMENTAL
Intervention: Active women (engaging in at least 150 min of moderate-intensity leisure-time physical activity per week)
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Active women
Number of subjects: 338
Study: 22764598

Group type: EXPERIMENTAL
Intervention: Moxibustion pretreatment of Guanyuan (CV 12) + bilateral Zusanli (ST 36) or Guanyuan (CV 12) + bilateral Sanyinjiao (SP 6) for 30 min, once a day for 4 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group: simple heavy load running training
Number of subjects: 12
Study: 20508907

Group type: EXPERIMENTAL
Intervention: Idraparinux (2.5 mg, once-weekly subcutaneous injection)
Number of subjects: 421

Group type: COMPARATOR
Intervention: Standard therapy (heparin followed by vitamin K antagonists)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Idraparinux
Number of subjects: 421

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 421
Study: 18251334

Group type: EXPERIMENTAL
Intervention: Body fat percentage (BF%)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Waist circumference (WC)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: BMI/WC as obesity measures
Number of subjects: 451
Study: 15821527

Group type: EXPERIMENTAL
Intervention: Functional Magnetic Stimulation (FMS)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 11321205

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Fire safety education (FSE)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Home visit from a firefighter (HVF)
Number of subjects: 54
Study: 9769818

Group type: EXPERIMENTAL
Intervention: Gadolinium-enhanced three-dimensional MR angiography
Number of subjects: 21
Study: 8142791

Group type: EXPERIMENTAL
Intervention: Self-directed treatment manual
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy
Number of subjects: 81

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 81
Study: 3344301

Group type: EXPERIMENTAL
Intervention: Biosituational feedback
Number of subjects: 64

Group type: COMPARATOR
Intervention: Internal cue feedback
Number of subjects: 64

Group type: COMPARATOR
Intervention: Situational cue feedback
Number of subjects: 64

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 64
Study: 2131504

Group type: EXPERIMENTAL
Intervention: Essential amino acids supplementation added to a protein restricted diet (0.6 g/kg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diet containing food with high biologic value
Number of subjects: 0
Study: 134723

Group type: EXPERIMENTAL
Intervention: ipratropiumbromide (0.02 mg per puff, 3 x 2 puffs)
Number of subjects: 25

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25
Study: 30739406

Group type: EXPERIMENTAL
Intervention: Bidirectional barbed suture
Number of subjects: 96

Group type: COMPARATOR
Intervention: PDS‐Ⅱ suture (control group)
Number of subjects: 96
Study: 27440140

Group type: EXPERIMENTAL
Intervention: EQ-5D health utility score
Number of subjects: 616

Group type: COMPARATOR
Intervention: Acute illness variables
Number of subjects: 616
Study: 25913498

Group type: EXPERIMENTAL
Intervention: SoluMatrix diclofenac 35 mg b.i.d. (which could be increased to t.i.d. as needed)
Number of subjects: 602
Study: 23912164

Group type: EXPERIMENTAL
Intervention: Web-based psycho-educational intervention for parents (AfterTheInjury.org [ATI])
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 21088959

Group type: EXPERIMENTAL
Intervention: Pramipexole (0.5 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 19207134

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4) 10 mmol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal saline (NSal)
Number of subjects: 48
Study: 17429905

Group type: EXPERIMENTAL
Intervention: PurFlo mattress
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional mattress
Number of subjects: 24
Study: 15109586

Group type: EXPERIMENTAL
Intervention: Rehabilitative approaches
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacological or surgical treatment
Number of subjects: 0
Study: 11394513

Group type: EXPERIMENTAL
Intervention: Proprietary propofol
Number of subjects: 40
Study: 10085701

Group type: EXPERIMENTAL
Intervention: Obese diabetic patients (BMI > 27.5)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Obese patients without diabetes (BMI > 27.5)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Normal weight diabetic patients (BMI < 27.5)
Number of subjects: 63
Study: 8291729

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia only (EA)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Combined epidural and general anesthesia (EG)
Number of subjects: 96

Group type: COMPARATOR
Intervention: General anesthesia only (GA)
Number of subjects: 96
Study: 2587002

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (3 cycles)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy and surgery or radiotherapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aggressive multimodal approach (including surgery)
Number of subjects: 60
Study: 31904695

Group type: EXPERIMENTAL
Intervention: Hemostasis with the TR Band device
Number of subjects: 600

Group type: COMPARATOR
Intervention: Conventional pressure dressing
Number of subjects: 600
Study: 31582271

Group type: EXPERIMENTAL
Intervention: Occupation-based bilateral upper extremity training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Task-based bilateral upper extremity training
Number of subjects: 20
Study: 29488475

Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs and an anxiolytic (adaptol)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Antihypertensive drugs only
Number of subjects: 125
Study: 25361980

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus everolimus
Number of subjects: 55

Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 55
Study: 23475369

Group type: EXPERIMENTAL
Intervention: Zinc supplement
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 21849041

Group type: EXPERIMENTAL
Intervention: Vinorelbine plus gemcitabine followed by docetaxel (VGD)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Paclitaxel plus carboplatin (PC)
Number of subjects: 68
Study: 19308789

Group type: EXPERIMENTAL
Intervention: 2 mg caffeine . kg(‐1) body mass (BM)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 4 mg caffeine . kg(‐1) BM
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 16393442

Group type: EXPERIMENTAL
Intervention: Armodafinil 100 mg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Armodafinil 150 mg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Armodafinil 200 mg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Armodafinil 300 mg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 15261318

Group type: EXPERIMENTAL
Intervention: 8% sevoflurane
Number of subjects: 50

Group type: COMPARATOR
Intervention: i.v. thiopental
Number of subjects: 50
Study: 11323595

Group type: EXPERIMENTAL
Intervention: Variable rigidity colonoscope (VRC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional colonoscope
Number of subjects: 50
Study: 9396910

Group type: EXPERIMENTAL
Intervention: 20 mg of dexamethasone in saline solution (study group, n = 50)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Saline solution only (control group, n = 48)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Not applicable (comparison of risks)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Not applicable (general success rate)
Number of subjects: 98
Study: 8192695

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 14
Study: 2879174

Group type: EXPERIMENTAL
Intervention: Fentanyl (10 micrograms/kg intravenously)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Non-fentanyl (nitrous oxide and d‐tubocurarine without fentanyl)
Number of subjects: 16
Study: 31240753

Group type: EXPERIMENTAL
Intervention: Cord clamping after 180 seconds
Number of subjects: 540

Group type: COMPARATOR
Intervention: Cord clamping within 60 seconds
Number of subjects: 540
Study: 29522941

Group type: EXPERIMENTAL
Intervention: Bupropion-SSRI combination
Number of subjects: 662

Group type: COMPARATOR
Intervention: SSRI monotherapy
Number of subjects: 662

Group type: COMPARATOR
Intervention: Venlafaxine-mirtazapine combination
Number of subjects: 662

Group type: EXPERIMENTAL
Intervention: Not applicable for overweight and obese I participants
Number of subjects: 662
Study: 27622558

Group type: EXPERIMENTAL
Intervention: Scheduled intermittent screening with malaria rapid diagnostic tests and treatment with dihydroartemisinin-piperaquine (ISTp-DP)
Number of subjects: 1873

Group type: COMPARATOR
Intervention: Intermittent preventive therapy with sulfadoxine-pyrimethamine (IPTp-SP)
Number of subjects: 1873
Study: 24755129

Group type: COMPARATOR
Intervention: Ticagrelor 600 mg (SAD study)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Ticagrelor 100 mg and 300 mg (MAD study)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Ticagrelor >= 100 mg (SAD study)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Ticagrelor (both studies)
Number of subjects: 112
Study: 22440079

Group type: EXPERIMENTAL
Intervention: FRIENDS program (cognitive behavior prevention program)
Number of subjects: 638
Study: 20502014

Group type: EXPERIMENTAL
Intervention: Rivastigmine 17.4 mg/24 h patch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rivastigmine 9.5 mg/24 h patch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rivastigmine capsules
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rivastigmine patches and capsules
Number of subjects: 0
Study: 18377401

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Motivational Intervention (MI)
Number of subjects: 468

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 468
Study: 16042935

Group type: EXPERIMENTAL
Intervention: Topical 5-aminolevulinic acid (ALA) and intense pulsed light (IPL)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Intense pulsed light (IPL) alone
Number of subjects: 13
Study: 12443968

Group type: EXPERIMENTAL
Intervention: 1.0% C31G co-polymer gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1.2% HEC gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2.0% N-9
Number of subjects: 0
Study: 10404349

Group type: EXPERIMENTAL
Intervention: Patients with left ventricular systolic dysfunction (CMP)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Patients with documented coronary artery disease (CAD)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control patients with normal systolic function
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: All groups (CMP, CAD, normal function)
Number of subjects: 41
Study: 7776074

Group type: EXPERIMENTAL
Intervention: Venoglobulin, 2 gm/kg (product A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Iveegam, 2 gm/kg (product B)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both products A and B
Number of subjects: 90
Study: 2176518

Group type: EXPERIMENTAL
Intervention: rHu‐EPO (erythropoietin)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no erythropoietin)
Number of subjects: 22
Study: 375850

Group type: EXPERIMENTAL
Intervention: Naproxen at 10 mg per kg body weight
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin at 80 mg per kg body weight
Number of subjects: 0
Study: 31755280

Group type: EXPERIMENTAL
Intervention: Visual educational leaflet
Number of subjects: 136

Group type: COMPARATOR
Intervention: Standard care (no leaflet)
Number of subjects: 136
Study: 28107821

Group type: EXPERIMENTAL
Intervention: Letrozole 20 mg administered when the dominant follicle reached 12 mm
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Letrozole 20 mg administered when the dominant follicle reached 18 mm
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Letrozole 20 mg administered on the first day following ovulation (post‐ovulation)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (treatment withheld)
Number of subjects: 45
Study: 27186989

Group type: EXPERIMENTAL
Intervention: Nebulizers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metered dose inhalers (MDIs) with spacers
Number of subjects: 0
Study: 24548781

Group type: EXPERIMENTAL
Intervention: Patient Information Leaflets (PILs)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Evaluation tool for PILs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PILs
Number of subjects: 20
Study: 22426749

Group type: EXPERIMENTAL
Intervention: HSCT (Hematopoietic Stem Cell Transplantation)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Transplanted patients
Number of subjects: 107
Study: 19752154

Group type: EXPERIMENTAL
Intervention: Moderate exercise (20 min cycle-ergometry at approximately 60% of age-predicted maximum heart rate)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sedentary (control group)
Number of subjects: 52
Study: 17574796

Group type: EXPERIMENTAL
Intervention: MDD
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: ADHD
Number of subjects: 167

Group type: COMPARATOR
Intervention: CD alone
Number of subjects: 167
Study: 15979021

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR 75 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR 150 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Venlafaxine groups
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 12180734

Group type: EXPERIMENTAL
Intervention: Cetylated fatty acids (CFA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (vegetable oil)
Number of subjects: 64
Study: 10599994

Group type: EXPERIMENTAL
Intervention: High-fat diet with preprandial exercise (Ex-FAT)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High-fat diet with postprandial exercise (FAT-Ex)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet with preprandial exercise (Ex-CHO)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet with postprandial exercise (CHO-Ex)
Number of subjects: 7
Study: 8961722

Group type: EXPERIMENTAL
Intervention: 30 mg dextroamphetamine (10 mg doses at midnight, 4 a.m., and 8 a.m.)
Number of subjects: 0
Study: 1301641

Group type: EXPERIMENTAL
Intervention: Meperidine administered via femoral block
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meperidine administered intravenously
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meperidine administered via interscalene block
Number of subjects: 0
Study: 3886301

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg) with chlorthalidone (12.5 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Atenolol (50 mg) alone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chlorthalidone (12.5 mg) alone
Number of subjects: 100
Study: 31047802

Group type: EXPERIMENTAL
Intervention: End-of-induction PET response after first-line immunochemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complete metabolic response
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No complete metabolic response
Number of subjects: 0
Study: 29277698

Group type: EXPERIMENTAL
Intervention: High fertility voice stimuli
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Voice ratings task
Number of subjects: 33

Group type: COMPARATOR
Intervention: Low fertility voice stimuli
Number of subjects: 33
Study: 26382733

Group type: EXPERIMENTAL
Intervention: Epratuzumab 100 mg Q2W
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epratuzumab 400 mg Q2W
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epratuzumab 600 mg QW
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epratuzumab 1200 mg Q2W
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epratuzumab (all doses)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 24689982

Group type: EXPERIMENTAL
Intervention: Viewing a pro-anorexia website
Number of subjects: 124

Group type: COMPARATOR
Intervention: Viewing control websites (fashion, home decoration, automutilation)
Number of subjects: 124
Study: 24438999

Group type: EXPERIMENTAL
Intervention: Family-based group cognitive-behavioral intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison condition
Number of subjects: 0
Study: 22553407

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midazolam plus Fentanyl (M/F)
Number of subjects: 0
Study: 19403595

Group type: EXPERIMENTAL
Intervention: PEEP of 10 cm H2O (Group P)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Inspiratory pressure of 40 cm H2O for 15 s once (Group R)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group R recruitment followed by PEEP 10 cm H2O (Group RP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group RP recruitment but with the inspiratory manoeuvre repeated every 10 min (Group RRP)
Number of subjects: 60
Study: 17330625

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 174

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 174
Study: 15681764

Group type: EXPERIMENTAL
Intervention: Oral insulin (1 mg/day)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Oral insulin (10 mg/day)
Number of subjects: 187
Study: 11120935

Group type: EXPERIMENTAL
Intervention: Thalidomide 100 mg orally, 3 times per week for 6 months
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo, 3 times per week for 6 months
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 49
Study: 9613081

Group type: EXPERIMENTAL
Intervention: 80 mg of long-acting propranolol hydrochloride-betacap (Natko, India)
Number of subjects: 48
Study: 7626966

Group type: EXPERIMENTAL
Intervention: Serotonin reuptake inhibitors (treatment duration: 10 to 12 weeks)
Number of subjects: 21
Study: 1720479

Group type: EXPERIMENTAL
Intervention: Isradipine (2.5 or 5 mg b.i.d.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (12.5 or 25 mg b.i.d.)
Number of subjects: 0
Study: 6184938

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with dextran
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low dose heparin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60